Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers have used AI technology to predict a patient’s chance of death, heart attack or stroke better than human doctors, sharing their findings in a new study in Circulation.
AI models can be trained to predict outcomes in meningioma patients, according to new research published in npjDigital Medicine. The study’s authors even developed a free smartphone app so others can explore their work.
AI promises to make a titanic impact on radiology, but most of the attention tends to focus on its ability to identify important findings in medical images. What about the technology’s non-interpretive qualities?
Machine learning-based algorithms can predict how patients will respond to antidepressants, according to new research published in Nature Biotechnology. The secret, the authors revealed, is electroencephalography (EEG) data.
Deep learning-based AI models can improve the segmentation of white matter in 18F-FDG PET/CT images, according to a new study published in the Journal of Digital Imaging. This helps radiologists with the early diagnosis of neurodegenerative disease.
President Trump’s 2021 budget proposal included significant cuts related to healthcare and science research, but AI received additional funding compared to 2020.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.